SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1

Xu,Xianzhi; Xu,Xianzhi; Mao,Yiting; Mao,Yiting; Feng,Zhaowei; Feng,Zhaowei; Dai,Feng; Dai,Feng; Gu,Teng; Gu,Teng; Zheng,Jiwei; Zheng,Jiwei

doi:10.3892/or.2023.8693

SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1

Authors:
- Xianzhi Xu
- Yiting Mao
- Zhaowei Feng
- Feng Dai
- Teng Gu
- Jiwei Zheng
View Affiliations

Affiliations: School of Stomatology, Xuzhou Medical University, Xuzhou, Jiangsu 221004, P.R. China, Department of Neurology, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221000, P.R. China, Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221000, P.R. China
Published online on: December 28, 2023 https://doi.org/10.3892/or.2023.8693
Article Number: 34
Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Head and neck squamous cell carcinoma (HNSCC) is currently one of the most common malignancies with a poor prognosis worldwide. Meanwhile, small ubiquitin‑like modifier (SUMO) specific peptidase 1 (SENP1) was associated with ferroptosis. However, the specific functions and underlying mechanisms of action of SENP1 in ferroptosis and tumor progression of HNSCC remain to be established. The findings of the present study implicated a novel ferroptosis pathway in the initiation and progression of HNSCC, providing new functional targets to guide future therapy. In the present study, The Cancer Genome Atlas database was employed to establish a gene model related to ferroptosis and verified SENP1 as a key gene via transcriptome sequencing. Expression of SENP1 in HNSCC tissue and CAL‑27 cells was detected based on reverse transcription‑quantitative PCR and western blot analysis. Proliferation and migration abilities of cells were determined using Cell Counting Kit‑8, wound healing and Transwell experiments. Expression levels of iron, glutathione (GSH) and lipid peroxidation end‑product malondialdehyde (MDA) under conditions of silencing of SENP1 with shRNA lentivirus were assayed. Additionally, the relationship between SENP1 and long‑chain acyl‑coenzyme A synthase 4 (ACSL4) was validated with the aid of immunoblotting and co‑immunoprecipitation (co‑IP). Finally, the influence of shSENP1 on the expression of key ferroptosis proteins, glutathione peroxidase 4 (GPX4) and solute carrier family 7 member 11, was evaluated via western blotting. It was revealed that SENP1 was significantly overexpressed in HNSCC and associated with low patient survival. Silencing of SENP1 led to significant suppression of cell proliferation, migration and invasion, increase in the contents of iron ions and MDA and decline in GSH levels in HNSCC cells, thereby enhancing ferroptosis and inhibiting disease progression. Conversely, overexpression of SENP1 suppressed ferroptosis and promoted progression of HNSCC. Co‑IP and western blot analyses revealed a SUMOylation link between SENP1 and ACSL4. SENP1 reduced the stability of ACSL4 protein through deSUMOylation, leading to inhibition of ferroptosis. SENP1 silencing further inhibited the expression of the key iron death protein, GPX4, to regulate ferroptosis. Taken together, SENP1 deficiency promoted ferroptosis and inhibited tumor progression through reduction of SUMOylation of ACSL4 in HNSCC. The collective results of the present study supported the utility of SENP1 as an effective predictive biomarker for targeted treatment of HNSCC.

View Figures

View References

1	Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE and Grandis JR: Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 6:922020. View Article : Google Scholar : PubMed/NCBI
2	Solomon B, Young RJ and Rischin D: Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments. Semin Cancer Biol. 52:228–240. 2018. View Article : Google Scholar : PubMed/NCBI
3	Kitamura N, Sento S, Yoshizawa Y, Sasabe E, Kudo Y and Yamamoto T: Current trends and future prospects of molecular targeted therapy in head and neck squamous cell carcinoma. Int J Mol Sci. 22:2402020. View Article : Google Scholar : PubMed/NCBI
4	Panarese I, Aquino G, Ronchi A, Longo F, Montella M, Cozzolino I, Roccuzzo G, Colella G, Caraglia M and Franco R: Oral and oropharyngeal squamous cell carcinoma: Prognostic and predictive parameters in the etiopathogenetic route. Expert Rev Anticancer Ther. 19:105–119. 2019. View Article : Google Scholar : PubMed/NCBI
5	Hanoteau A, Newton JM, Krupar R, Huang C, Liu HC, Gaspero A, Gartrell RD, Saenger YM, Hart TD, Santegoets SJ, et al: Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy. J Immunother Cancer. 7:102019. View Article : Google Scholar : PubMed/NCBI
6	Göttgens EL, Ostheimer C, Span PN, Bussink J and Hammond EM: HPV, hypoxia and radiation response in head and neck cancer. Br J Radiol. 92:201800472019.PubMed/NCBI
7	Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al: Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
8	Zhang C, Liu X, Jin S, Chen Y and Guo R: Ferroptosis in cancer therapy: A novel approach to reversing drug resistance. Mol Cancer. 21:472022. View Article : Google Scholar : PubMed/NCBI
9	Zhao L, Zhou X, Xie F and Zhang L, Yan H, Huang J, Zhang C, Zhou F, Chen J and Zhang L: Ferroptosis in cancer and cancer immunotherapy. Cancer Commun (Lond). 42:88–116. 2022. View Article : Google Scholar : PubMed/NCBI
10	Xu L, Li YY, Zhang YC, Wu YX, Guo DD, Long D and Liu ZH: A novel ferroptosis-related gene signature to predict prognosis in patients with head and neck squamous cell carcinoma. Dis Markers. 2021:57599272021. View Article : Google Scholar : PubMed/NCBI
11	Lu T, Zhang Z, Pan X, Zhang J, Wang X, Wang M, Li H, Yan M and Chen W: Caveolin-1 promotes cancer progression via inhibiting ferroptosis in head and neck squamous cell carcinoma. J Oral Pathol Med. 51:52–62. 2022. View Article : Google Scholar : PubMed/NCBI
12	Yau TY, Sander W, Eidson C and Courey AJ: SUMO interacting motifs: Structure and function. Cells. 10:28252021. View Article : Google Scholar : PubMed/NCBI
13	Zhao X: SUMO-mediated regulation of nuclear functions and signaling processes. Mol Cell. 71:409–418. 2018. View Article : Google Scholar : PubMed/NCBI
14	Li H, Chen L, Li Y and Hou W: SUMO-specific protease 1 inhibitors-A literature and patent overview. Expert Opin Ther Pat. 32:1207–1216. 2022. View Article : Google Scholar : PubMed/NCBI
15	Gao Y, Wang R, Liu J, Zhao K, Qian X, He X and Hong L: SENP1 promotes triple-negative breast cancer invasion and metastasis via enhancing CSN5 transcription mediated by GATA1 deSUMOylation. Int J Biol Sci. 18:2186–2201. 2022. View Article : Google Scholar : PubMed/NCBI
16	Dong B, Gao Y, Kang X, Gao H, Zhang J, Guo H, You MJ, Xue W, Cheng J and Huang Y: SENP1 promotes proliferation of clear cell renal cell carcinoma through activation of glycolysis. Oncotarget. 7:80435–80449. 2016. View Article : Google Scholar : PubMed/NCBI
17	Sun W, Liu X, Yang X, Jing X, Duan C, Yang G, Wu C, Huang H, Luo Q, Xia S, et al: SENP1 regulates the transformation of lung resident mesenchymal stem cells and is associated with idiopathic pulmonary fibrosis progression. Cell Commun Signal. 20:1042022. View Article : Google Scholar : PubMed/NCBI
18	Bai YT, Xiao FJ, Wang H, Ge RL and Wang LS: Hypoxia protects H9c2 cells against ferroptosis through SENP1-mediated protein DeSUMOylation. Int J Med Sci. 18:1618–1627. 2021. View Article : Google Scholar : PubMed/NCBI
19	Kuwata H and Hara S: Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism. Prostaglandins Other Lipid Mediat. 144:1063632019. View Article : Google Scholar : PubMed/NCBI
20	Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A, et al: ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 13:91–98. 2017. View Article : Google Scholar : PubMed/NCBI
21	Chen X, Li J, Kang R, Klionsky DJ and Tang D: Ferroptosis: Machinery and regulation. Autophagy. 17:2054–2081. 2021. View Article : Google Scholar : PubMed/NCBI
22	Quan J, Bode AM and Luo X: ACSL family: The regulatory mechanisms and therapeutic implications in cancer. Eur J Pharmacol. 909:1743972021. View Article : Google Scholar : PubMed/NCBI
23	Blum A, Wang P and Zenklusen JC: SnapShot: TCGA-analyzed tumors. Cell. 173:5302018. View Article : Google Scholar : PubMed/NCBI
24	Onofri A, Terzaroli N and Russi L: Linear models for diallel crosses: A review with R functions. Theor Appl Genet. 134:585–601. 2021. View Article : Google Scholar : PubMed/NCBI
25	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
26	He F, Chen Z, Deng W, Zhan T, Huang X, Zheng Y and Yang H: Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma. Int Immunopharmacol. 98:1077892021. View Article : Google Scholar : PubMed/NCBI
27	Wang W, Zhang J, Wang Y, Xu Y and Zhang S: Identifies microtubule-binding protein CSPP1 as a novel cancer biomarker associated with ferroptosis and tumor microenvironment. Comput Struct Biotechnol J. 20:3322–3335. 2022. View Article : Google Scholar : PubMed/NCBI
28	Zhu T, Shi L, Yu C, Dong Y, Qiu F, Shen L, Qian Q, Zhou G and Zhu X: Ferroptosis promotes photodynamic therapy: Supramolecular photosensitizer-inducer nanodrug for enhanced cancer treatment. Theranostics. 9:3293–3307. 2019. View Article : Google Scholar : PubMed/NCBI
29	Han ZJ, Feng YH, Gu BH, Li YM and Chen H: The post-translational modification, SUMOylation, and cancer (Review). Int J Oncol. 52:1081–1094. 2018.PubMed/NCBI
30	Wang X, Liang X, Liang H and Wang B: SENP1/HIF-1α feedback loop modulates hypoxia-induced cell proliferation, invasion, and EMT in human osteosarcoma cells. J Cell Biochem. 119:1819–1826. 2018. View Article : Google Scholar : PubMed/NCBI
31	Hao L, Dong Y, Zhang JJ, He HG, Chen JG, Zhang SQ, Zhang QJ, Wu W, Han CH and Shi ZD: Melatonin decreases androgen-sensitive prostate cancer growth by suppressing SENP1 expression. Transl Androl Urol. 11:91–103. 2022. View Article : Google Scholar : PubMed/NCBI
32	Shen X, Ni R, Qian X, Yu C, Wu H, Ni J, Zhu W and Gao X: A verification study on the genes associated with laryngeal squamous cell carcinoma by cDNA microarray. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 24:411–413. 2010.(In Chinese). PubMed/NCBI
33	Gao C, Xiao F, Zhang L, Sun Y and Wang L, Liu X, Sun H, Xie Z, Liang Y, Xu Q and Wang L: SENP1 inhibition suppresses the growth of lung cancer cells through activation of A20-mediated ferroptosis. Ann Transl Med. 10:2242022. View Article : Google Scholar : PubMed/NCBI
34	Vertegaal ACO: Signalling mechanisms and cellular functions of SUMO. Nat Rev Mol Cell Biol. 23:715–731. 2022. View Article : Google Scholar : PubMed/NCBI
35	Mevissen TET and Komander D: Mechanisms of deubiquitinase specificity and regulation. Annu Rev Biochem. 86:159–192. 2017. View Article : Google Scholar : PubMed/NCBI
36	Kukkula A, Ojala VK, Mendez LM, Sistonen L, Elenius K and Sundvall M: Therapeutic potential of targeting the SUMO pathway in cancer. Cancers (Basel). 13:44022021. View Article : Google Scholar : PubMed/NCBI
37	Bawa-Khalfe T, Yang FM, Ritho J, Lin HK, Cheng J and Yeh ET: SENP1 regulates PTEN stability to dictate prostate cancer development. Oncotarget. 8:17651–17664. 2017. View Article : Google Scholar : PubMed/NCBI
38	Sun XX, Chen Y, Su Y, Wang X, Chauhan KM, Liang J, Daniel CJ, Sears RC and Dai MS: SUMO protease SENP1 deSUMOylates and stabilizes c-Myc. Proc Natl Acad Sci USA. 115:10983–10988. 2018. View Article : Google Scholar : PubMed/NCBI